Revolution Medicines, Inc.
RVMD · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$305 | -$248 | -$213 | -$195 |
| Dep. & Amort. | $4 | -$21 | $4 | $3 |
| Deferred Tax | $0 | $0 | $0 | -$1 |
| Stock-Based Comp. | $0 | $29 | $25 | $0 |
| Change in WC | $37 | -$4 | $2 | $43 |
| Other Non-Cash | $57 | $22 | -$12 | $11 |
| Operating Cash Flow | -$207 | -$222 | -$194 | -$138 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$3 | -$7 | -$3 | -$1 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | -$529 | -$510 | -$695 |
| Inv. Sales/Matur. | $0 | $571 | $497 | $304 |
| Other Inv. Act. | $28 | $0 | $0 | $0 |
| Investing Cash Flow | $25 | $34 | -$16 | -$393 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $7 | $0 | $874 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$2 | $250 | $1 | $0 |
| Financing Cash Flow | -$2 | $257 | $1 | $874 |
| Forex Effect | $0 | $0 | $0 | -$1 |
| Net Chg. in Cash | -$184 | $69 | -$210 | $342 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $406 | $337 | $547 | $201 |
| End Cash | $222 | $406 | $337 | $543 |
| Free Cash Flow | -$211 | -$229 | -$198 | -$140 |